Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Aside from share price ... smells right for some bolt-ons

<< Previous

Bullboard Posts

Next >>

Comment by Chianchinon Jan 17, 2023 6:14am

112 Views

Post# 35227162

RE:RE:RE:RE:RE:RE:RE:RE:Aside from share price ... smells right for some bolt-ons

The north America media does not report much to what is happening in LATAM or careless. Read latam papers and use google translate. I had to cancel my vacation to latam that was to starting next week. Try to book a trip to latam? Mugsy's head deep in the sand knows it all but does not face reality

<< Previous

Bullboard Posts

Next >>

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload